Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Head-to-Head Comparison of 18-Gene-Based Clinical-Genomic Model and Oncotype DX 21-Gene Assay for Predicting Recurrence of Early-stage Breast Cancer

NCT03772197 is registered in ClinicalTrials.gov with Amwise Diagnostics Pte. Ltd. as lead sponsor.

NCT NCT03772197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03772197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Head-to-Head Comparison of 18-Gene-Based Clinical-Genomic Model and Oncotype DX 21-Gene Assay for Predicting Recurrence of Early-stage Breast Cancer
Lead sponsor
Amwise Diagnostics Pte. Ltd.
Phase
Observational
Overall status
Completed
Start date
June 1, 2018
Completion date
November 1, 2018
Enrollment
138 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, recurrence